Europe Colorectal Cancer Market by Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), by Treatment (Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Colorectal Cancer Market by Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), by Treatment (Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 616 | Pages: 133 | October 2016 | Region: Europe


The Europe Colorectal Cancer Market was worth $3.39 billion in 2016 and estimated to be growing at a CAGR of 2.45%, to reach $3.83 billion by 2021. Colorectal cancer is a consequence of unrestrained cell growth that occurs in the appendix, colon, and the rectum region. Some of the generally seen symptoms of colorectal cancer are blood in the stool, weight loss, fatigue, and irregular bowel movements.

Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.

Rise in pipeline colorectal cancer screening tests is one of the major driver for the colorectal cancer market in this region. Another aspect is that European countries face comparable economic and demographic burdens and share an interest in scrutinizing their impact on health outcomes nationally and across Europe. However, high cost of treatment is one of the main factors hindering the growth of this market.

The Europe Colorectal Cancer Market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.

The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. European is the third largest market with a global share of 24%. Germany is the largest market share holder for the colorectal Cancer market in this region, followed by the UK and France. Other significant markets in the region are Norway, Netherlands, Denmark, and Greece.

The major companies dominating the market in this region are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Diagnosis               

                                5.1.1 Digital Rectal Examination

                                5.1.2 Faecal Occult Blood Test

                                5.1.3 Flexible Sigmoidoscopy

                                5.1.4 Colonoscopy

                                5.1.5 Virtual Colonoscopy

                5.2 By Treatment            

                                5.2.1 Surgery and Radiation Therapy

                                5.2.2 Chemotherapy

                                5.2.3 Targeted Therapies

                                5.2.4 Resistance to Pharmacological Therapies

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 U.K

                                6.3 Spain

                                6.4 Germany

                                6.5 Italy 

                                6.6 France

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Abbott Diagnostics  

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Alere             

                8.3 Beckman Coulter     

                8.4 Clinical Genomics     

                8.5 Companion Dx          

                8.6 Hoffmann La Roche

                8.7 Debiopharm Group 

                8.8 Vaccinogen BD          

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Colorectal Cancer Market By Region, From 2016-2021 (USD Billion)
  2. Europe Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  3. Europe Digital Rectal Examination Market By Region, From 2016-2021 (USD Billion)
  4. Europe Faecal Occult Blood Test Market By Region, From 2016-2021 (USD Billion)
  5. Europe Flexible Sigmoidoscopy Market By Region, From 2016-2021 (USD Billion)
  6. Europe Colonoscopy Market By Region, From 2016-2021 (USD Billion)
  7. Europe Virtual Colonoscopy Market By Region, From 2016-2021 (USD Billion)
  8. Europe Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  9. Europe Surgery and Radiation Therapy Market By Region, From 2016-2021 (USD Billion)
  10. Europe Chemotherapy Market By Region, From 2016-2021 (USD Billion)
  11. Europe Targeted Therapies Market By Region, From 2016-2021 (USD Billion)
  12. Europe Resistance to Pharmacological Therapies Market By Region, From 2016-2021 (USD Billion)
  13. U.K Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  14. U.K Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  15. Spain Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  16. Spain Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  17. Germany Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  18. Germany Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  19. Italy Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  20. Italy Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  21. France Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  22. France Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...
Middle East and Africa Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Ret...
Latin America Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharm...
Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharma...
Europe Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by end user (Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies....
North America Market Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user (Hospital, Oncology centers, Hospital Pharmacies and Reta...
Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.